Clinical Trials

300 enrolled

Carcinoma, Transitional Cell, Neoplasms

NCT06412848 2026-02-24

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

360 enrolled

Carcinoma, Transitional Cell

NCT06657157 2026-02-24

P-EVOLUTION

80 enrolled

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT06138561 2026-02-17

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

180 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06724159 2026-02-17

SOGUG-PRINCIS

500 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07390617 2026-02-05

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

50 enrolled

Carcinoma, Transitional Cell

NCT07386847 2026-02-04

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

Not yet recruiting

3,000 enrolled

Carcinoma, Transitional Cell

NCT07339878 2026-01-14

FLORAL

50 enrolled

Carcinoma, Transitional Cell

NCT07334314 2026-01-12

OUAF

340 enrolled

Carcinoma, Transitional Cell

NCT03782207 2026-01-08

IMreal

GastrointestinalGenitourinaryThoracic

2,756 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT06870253 2026-01-06

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

80 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria

NCT06120374 2025-12-30

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

178 enrolled

Carcinoma, Transitional Cell

NCT06129084 2025-12-15

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

260 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07037589 2025-11-21

BLUSH

300 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms

NCT05889195 2025-10-31

microDRIVE

1,000 enrolled

Carcinoma, Transitional Cell

NCT06396533 2025-10-31

INSITE

92 enrolled

Carcinoma, Transitional Cell

NCT06310759 2025-10-10

UROSCOUT-1

3,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03374267 2025-09-22

CARAT

1,930 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT04892849 2025-09-17

ST-ICI02

GastrointestinalGenitourinaryHead & Neck

200 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms

NCT07072637 2025-07-18

Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy

Not yet recruiting

100 enrolled

Carcinoma, Transitional Cell

NCT06421311 2025-06-05

URADJ

Terminated

176 enrolled

Carcinoma, Transitional Cell

NCT06982794 2025-05-21

Urolife

50 enrolled

Carcinoma, Transitional Cell

NCT05945108 2025-04-11

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Completed

400 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06912672 2025-04-08

UMT-UC

Not yet recruiting

1,500 enrolled

Carcinoma, Transitional Cell, Hematuria

NCT05431777 2025-04-01

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

Completed

79 enrolled 20 charts